Treatments after second progression in metastatic colorectal cancer: A pooled analysis of the TRIBE and TRIBE2 studies

Rossini, D; Germani, MM; Lonardi, S; Pietrantonio, F; Dell'Aquila, E; Borelli, B; Allegrini, G; Maddalena, G; Randon, G; Marmorino, F; Zaniboni, A; Buonadonna, A; Boccaccino, A; Conca, V; Antoniotti, C; Passardi, A; Masi, G; Cremolini, C

Cremolini, C (通讯作者),Azienda Ospedaliero Univ Pisana, Unit Med Oncol 2, Via Roma 67, I-56127 Pisa, Italy.

EUROPEAN JOURNAL OF CANCER, 2022; 170 (): 64

Abstract

Background: The availability of new drugs in the chemo-refractory setting opened the way to the concepts of treatment sequencing in mCRC. However, the......

Full Text Link